FDA Requires Label Change For Yaz And Other Drospirenone Birth Control Pills Due To Risk Of Blood Clots

The FDA has concluded that Drospirenone birth control pills, like Yaz and Yasmin, are associated with a higher risk of blood clots. Specifically, some studies showed a risk three times higher than that of other birth control pills. The labels will indicate this risk.

There is currently litigation pending regarding the side effects of these drugs. I am currently representing women who have been injured by them. Some of the side effects can include:

* Pulmonary embolism (PE)
* Deep vein thrombosis (DVT)
* Weight Gain
* Blood Clots
* Depression
* Kidney Failure
* Seizures
* Stroke
* Heart attack
* Pancreatitis
* Gallbladder disease
* Supra Vesicular Tachycardia (SVT)
* Heart arrhythmia and palpitations